Marsh & McLennan Consulting Revenue Jumps 9% in Q3
MRSH is trading near its 52-week low of $156.6 (14% above the low).
Summary
Marsh & McLennan's consulting arm posted 9% revenue growth in the third quarter, with consulting revenue of $2.7B, a strong print for the segment. This follows Q2 results in July that showed 5% underlying revenue growth and 9% adjusted EPS growth, so the consulting acceleration is a notable step up. Consulting is a key profit driver for the company, and 9% growth suggests healthy demand despite broader macro uncertainty. The full Q3 picture is now clear: risk and insurance services revenue rose 7% to $4.2B, total revenue was $6.86B, and underlying revenue rose 5%. EPS was $1.69 and adjusted EPS was $2.03. GAAP operating income rose 4% to $1.2B and adjusted operating income rose 6% to $1.5B, while nine-month adjusted EPS rose 9% to $8.29. The company also repurchased about 2.7 million shares of stock for $500 million in the quarter.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — Marsh Q3 2026 GAAP operating income rose 4% to $1.2B and adjusted operating income rose 6% to $1.5B; nine-month adjusted EPS rose 9% to $8.29.
At the time of this announcement, MRSH was trading at $178.40 on NYSE in the Finance sector, with a market capitalization of approximately $85.1B. The 52-week trading range was $156.60 to $207.28. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.